- Thinly traded micro cap Merus Labs International (NASDAQ:MSLI -22.6%) slumps on a 12x surge in volume, albeit on turnover of only 129K shares, in response to its fiscal Q3 results released this morning. Sales and adjusted EBITDA were up nicely, but the company lowered its 2016 guidance for non-GAAP EBITDA to $43M - 46M from $47M - 50M citing higher-than-planned expenses.
Merus fiscal Q3 top line up 171%, non-GAAP EBITDA up 88%, lower guidance sinks shares
Recommended For You
More Trending News
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| MSLI | - | - |
| Merus Labs International, Inc. | ||